Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene
Phase 1
- Conditions
- Chronic Myeloid LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
- Interventions
- First Posted Date
- 2016-08-31
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Fusion Pharma LLC
- Target Recruit Count
- 65
- Registration Number
- NCT02885766
- Locations
- 🇷🇺
Federal Haematological Scientific Center, Moscow, Russian Federation
🇷🇺Moscow City Centre of Hematology based on City Hospital named by S.Botkin, Moscow, Russian Federation
🇷🇺Federal Almazov North-West Medical Research Centre, St. Petersburg, Russian Federation
News
No news found